New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to ...

Best Outcomes with Systolic BP of 130-139 mm Hg New study also shows that uncontrolled vs. controlled resistant hypertension increases ESRD and cerebrovascular accident risk. Individuals with ...

Use of sacubitril/valsartan in resistant hypertension will depend on strategies that integrate close monitoring and multidisciplinary care.

In the Bax24 study reported at the AHA, aldosterone synthase inhibitor (ASI) baxdrostat achieved a 16.6 mm Hg reduction in 24 ...

Please provide your email address to receive an email when new articles are posted on . Resistant and refractory hypertension represent distinct disease states requiring different treatments. A ...

May 22, 2012 (New York, New York) — An analysis from a large US database of patients with high blood pressure has shown that individuals with resistant hypertension have significantly elevated risks ...

A new study has investigated the influence of xanthine oxidase activity and mitochondrial DNA damage–associated molecular patterns on heart failure and cardiac remodeling among Black adults with ...

High blood pressure is a major problem for older adults in the United States, with more than half of people over age 50 dealing with some form of hypertension. If left untreated, high blood pressure ...

AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.

NKF 2017-obese patient in doctor office, obesity blood pressure Most patients with CKD and apparent treatment-resistant hypertension had uncontrolled resistant hypertension or refractory hypertension.